Scott Kinlay։ Cancer and Adverse Outcomes Over 5 Years After Coronary Stenting and Optimal DAPT Duration
Scott Kinlay, Chief of Cardiology at VA Boston Healthcare System and Associate Professor of Medicine at Harvard Medical School, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Just published: Ramael Ohiomoba and Edwin Mandieka’s paper examines the relationship of cancer to adverse outcomes over 5 years after coronary stenting, as well as the optimal duration DAPT.
Key findings were that cancer patients have higher rates of myocardial infarction and major bleeding after PCI compared to non-cancer patients. The analysis also supports a similar duration of DAPT after PCI in cancer patients as non-cancer patients.”
Title: Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary intervention
Authors: Ramael Ohiomoba, Edwin Mandieka, Melissa M Young, David R Gagnon, Scott Kinlay
Read the Full Article on European Heart Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 16, 2026, 04:29Vijay Shah: Increasing Value of AI-Based Assessment in Cardiovascular Risk Prediction
-
Apr 16, 2026, 04:13Mysa Saad: Antiplatelets Increase Bleeding Without Reducing VTE in Cancer Patients
-
Apr 16, 2026, 04:11Paolo Zamboni: Enjoy the New Super Articles From Veins and Lymphatics Page Press
-
Apr 16, 2026, 04:03Platelet DGD – A Common But Underdiagnosed Bleeding Disorder – RPTH
-
Apr 16, 2026, 03:51William Wallace: How Vitamin B12 Is Being Absorbed?
-
Apr 16, 2026, 03:36Santagata Davide: Atypical Vascular Events Revealing Underlying Clonal Autoinflammation
-
Apr 16, 2026, 03:35Iron Deficiency in Women During Reproductive Years – ASH
-
Apr 16, 2026, 03:33Abdallah Othman: Overview of Coronary Arterial Anatomy and Its Clinical Implications
-
Apr 16, 2026, 03:14Laura Girardi: A Survey Study on the Management of Incidental Pulmonary Embolism in Patients with Cancer